CM
KYNB

Caption Management’s Kyntra Bio KYNB Stock Holding History

Caption Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,628
Closed -$2.94M – 1351
2023
Q2 		$2.94M Buy
43,628
+36,708
+530% +$15.2M 0.05% 406
2023
Q1 		$3.23M Buy
+6,920
New +$3.66M 0.06% 328
2022
Q2 		– Sell
-3,200
Closed -$961K – 1557
2022
Q1 		$961K Hold
3,200
– – 0.01% 991
2021
Q4 		$1.13M Buy
3,200
+260
+9% +$81K 0.01% 1004
2021
Q3 		$751K Sell
2,940
-31,972
-92% -$11.3M 0.01% 1107
2021
Q2 		$23.2M Buy
+34,912
New +$20.1M 0.3% 59
2021
Q1 		– Sell
-1,500
Closed -$1.39M – 1160
2020
Q4 		$1.39M Buy
+1,500
New +$1.58M 0.03% 535
2020
Q1 		– Sell
-1,800
Closed -$1.93M – 920
2019
Q4 		$1.93M Buy
+1,800
New +$1.84M 0.06% 360
2019
Q3 		– Sell
-600
Closed -$678K – 772
2019
Q2 		$678K Buy
+600
New +$657K 0.03% 433
2019
Q1 		– Sell
-800
Closed -$926K – 620
2018
Q4 		$926K Buy
+800
New +$899K 0.07% 266

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GC
GFG Capital Miami, Florida $363M AUM 45.53% 1-Year Est. Return

Caption Management's KYNB Position: Q3 2024 in Review

Caption Management sold out of Kyntra Bio (KYNB) in Q3 2024, closing a stake of 3,624 shares — an estimated $80.8K sold.

Caption Management first reported a position in KYNB in Q4 2018 and held it in 14 quarters. The position peaked at $6.68M in Q1 2023. 70 funds tracked by Wall St. Rank hold KYNB as of Q3 2024.

  • Caption Management reported no remaining Kyntra Bio position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 3,624 Kyntra Bio shares in Q3 2024, an estimated $80.8K.
  • Caption Management first reported a position in Kyntra Bio in Q4 2018 and held it in 14 quarters.
  • Caption Management's Kyntra Bio position peaked at $6.68M in Q1 2023.
  • 70 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.